Keyphrases
Pancreatic Cancer
86%
MT1-MMP
73%
Collagen
62%
Pancreatic Ductal Adenocarcinoma
62%
Pancreatic Cancer Cells
50%
Transforming Growth Factor-β
44%
Tumor
43%
Three-dimensional (3D)
38%
Pancreatic Duct Cells
34%
Immune Checkpoint Inhibitors
30%
Fibrosis
30%
Pancreatic Cancer Progression
27%
Bromodomain
24%
Gemcitabine
24%
KRAS G12C
24%
Epithelial-mesenchymal Transition
24%
Human Pancreatic Ductal Adenocarcinoma
24%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
23%
ERK2
21%
Collagen I
20%
Phosphorylation
20%
TGF Signaling
20%
Cancer Cells
20%
Matrix metalloproteinase-9 (MMP-9)
18%
Chemotherapy
17%
Motility
17%
TGF-1
17%
Matrix Metalloproteinases
17%
Pancreas
17%
Oral Keratinocytes
17%
Mouse Model
16%
5-lipoxygenase (5-LOX)
15%
Proteinase
15%
Epithelial-to-mesenchymal Transition
15%
Mast Cells
14%
Cancer Invasion
14%
Type I Collagen
14%
Clinical Trials
14%
HMGA2
14%
Transcription Factor
13%
Pancreatic Tumor
13%
Pancreatic Stellate Cells
13%
Gemcitabine Resistance
13%
Oral Squamous Cell Carcinoma Cells
13%
Pancreatic Tumorigenesis
13%
Tumor Immunity
13%
Protein Kinase
13%
TIMP-2
12%
Bromodomain-containing Protein 4 (BRD4)
12%
Tumor Progression
12%
Medicine and Dentistry
Pancreas Cancer
100%
Pancreas Adenocarcinoma
71%
Cancer Cell
51%
Matrix Metalloproteinase 14
47%
Neoplasm
43%
Snail
31%
Chemotherapy
30%
Immunity
29%
Mouth Squamous Cell Carcinoma
29%
Mesenchymal-Epithelial Transition
27%
Diseases
24%
Cancer Growth
24%
Malignant Neoplasm
24%
Fibrinogen
23%
Cancer Growth Factor
23%
Carcinogenesis
20%
Fibrosis
19%
Metastatic Carcinoma
19%
Gemcitabine
18%
Mitogen Activated Protein Kinase 3
17%
Gelatinase B
17%
Matrix Metalloproteinase
16%
Oral Cancer
16%
In Vitro
16%
Mast Cell
14%
Cell Invasion
14%
Immunotherapy
14%
Extracellular Matrix
14%
Isotopes of Calcium
13%
Mitogen-Activated Protein Kinase
13%
Prostate Cancer
12%
Tissue Inhibitor of Metalloproteinase 2
12%
Clear Cell Renal Cell Carcinoma
11%
p38 Mitogen-Activated Protein Kinase
11%
Metabolic Syndrome
11%
Carcinoma Cell
11%
Pancreatic Tumor Microenvironment
11%
Arachidonate 5 Lipoxygenase
11%
Cystic Fibrosis
11%
Clinical Trial
10%
Collagen Type 1
10%
Integrin
10%
Tumor Invasion
10%
Epithelial Cell
10%
Tumor Cell
9%
Proteinase
9%
Tumor Microenvironment
9%
Tumor Progression
9%
Immune Checkpoint Inhibitor
8%
Keratinocyte
8%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
81%
Membrane-Type Matrix Metalloproteinase-1
73%
Bromodomain
36%
Carcinogenesis
31%
Gemcitabine
24%
Immune Checkpoints
23%
Cancer Growth Factor
23%
Mesenchymal-Epithelial Transition
21%
Mouse Model
19%
Stellate Cell
18%
Fibrinogen
18%
Cadherin
16%
Cell Invasion
16%
Protease
15%
BRD4
15%
Protein Tertiary Structure
15%
Clinical Trial
14%
Mitogen-Activated Protein Kinase
13%
Keratinocyte
13%
Type I Collagen
13%
PD-L1
13%
Metalloprotease Inhibitor
12%
Matrix Metalloproteinase
12%
Cell Adhesion
12%
Transcription Factors
11%
High-Mobility Group
11%
Integrin
11%
Small Interfering RNA
10%
Immunity
9%
Interferon
9%
KRAS
8%
MMP9
8%
Gelatinase B
8%
Upregulation
8%
Transcription Factor Slug
7%
Overall Survival
7%
Mediator
7%
Translating (Language)
7%
P38 Mitogen-Activated Protein Kinases
7%
MMP2
7%
Gelatinase A
7%
Messenger RNA
7%
Collagen Gel
7%
Histone Acetylation
7%
Calmodulin
6%
Drug Resistance
6%
Cell Migration
6%
Urokinase
6%
Epidermal Growth Factor Receptor
6%
Histone Acetyltransferase
6%